CONMED Corporation (CNMD)Fuller & Thaler Asset Management, Inc. added to its stake +1.45M shares

3.18M

Shares reported · +1.45M vs prior quarter

0.22%

Disclosed portfolio weight

$129M

Reported value

Holdings as of

Dec 31, 2025

Filed

Feb 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, CONMED Corporation (the “ Company ”) announced the separation of Mr. Todd Garner, the Company’s Chief Financial Officer (“ CFO ”), effective on the earlier of March 15, 2026 or the date on which the Company appoints a new permanent CFO (the “ CFO Transition Date ”).”
2. Jan 28, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Mar 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 13, 2026, CONMED Corporation (the “Company”) announced that Andrew Moller, age 51, will be appointed Interim Principal Financial Officer of the Company effective March 15, 2026.”
2. Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
3. May 18, 2026Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year (and 1 more item)“On May 19, 2026, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.”
4. May 27, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
5. Jun 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
6. Jun 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 17, 2026, CONMED Corporation (the “Company”) announced that John E. Gallagher has been appointed to serve as the Company’s Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the “Effective Date”).”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for CONMED Corporation

For CONMED Corporation, OQRO holds 2 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CNMD page.

How this filing works

• SEC Form 13F

Other disclosures at CONMED Corporation

• SEC Form 13F-HRAug 13, 2026
• USAspending.gov award recordJul 31, 2026
• SEC Form 13F-HRJul 30, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 4, 2026
• SEC Form 13F-HRFeb 17, 2026

Everything OQRO holds on this company is on its CNMD page.